Sales & Marketing
shapes pricing and access

How transparent is the VPAS?

The UK’s VPAS – a deal that began on 1st January 2019 and which is due to end on 31st December 2023 – is worth around £7 billion.

Sales & Marketing

Sales & Marketing
shapes pricing and access

How transparent is the VPAS?

The UK’s VPAS – a deal that began on 1st January 2019 and which is due to end on 31st December 2023 – is worth around £7 billion.

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
12 Questions with David Long

12 Questions with David Long

David Long leads the Oncology Business Unit at MSD in the UK and brings a wealth of experience from his 20 years within the organisation, having held a variety of local, regional and global

Patients

R&D

R&D
Health Innovators Jennifer Schranz

Health Innovators – Jennifer Schranz

In the rare and ultra-rare disease space, the paucity of both data and patients makes everything about research and development more complicated.